NIH funds study of type 1 diabetes development
Weill Cornell Medicine has received a four-year, $3.4 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases, part of the National Institutes of Health, for a study of the details and dynamics of the autoimmune process that causes type 1 diabetes. Dr. Shuibing Chen, the Kilts Family Professor of Surgery and director of the Center for Genomic Health at Weill Cornell Medicine, will lead the project. Dr. Chen’s long-time collaborator, Dr. Stephen Parker, professor of computational medicine and bioinformatics, human genetics and biostatistics, and director of the Epigenomic Metabolic Medicine Center (EM2C) at the Caswell ...